Press Release | October 15, 2025
Press & Publications
Meet us
European College of Neuropsychopharmacology (ECNP) Conference
From 11th to 14th October 2025 in Amsterdam
Join us on October 14th for the presentation of our latest research during Poster Session 4, at 12:35 pm CET. Our work titled “RNA editing signatures powered by artificial intelligence: a new frontier in differentiating schizophrenia, bipolar and schizoaffective disorders” (poster PS04-3308) will be presented by our CSO, Dr. Dinah Weissmann. Joining her will be our Deputy Scientific Director Dr. Francisco Santos Schneider.
Looking forward to discussing the latest advancements in Precision medicine, Artificial Intelligence and computational models, and Biomarkers!
Press
Press Release | September 25, 2025
ALCEDIAG, OM Pharma Suisse and Unilabs Announce Swiss Launch of EDIT-B®, the World’s First Blood Test to Help Differentiate Depression and Bipolar Disorder
Press Release | September 09, 2025
ALCEDIAG successfully completes European multicentric study, further validating clinical performance of the first-in-class diagnostic test EDIT-B to differentiate unipolar depression from bipolar disorder
Award | April 26, 2024
Winner of the Medical Biology Award – Grands Prix Check Up Santé 2024
Press Release | March 22, 2024
SYNLAB et ALCEDIAG lancent en France le test sanguin myEDIT-B pour différencier la dépression et les troubles bipolaires.
Press Release | December 07, 2023
ALCEDIAG receives BPI France grant for EDIT-B® blood test clinical utility study
Press Release | November 06, 2023
50% Recruitment milestone reached in clinical validation study of EDIT B blood test: An aid for differential diagnosis of bipolar disorder based on RNA Editing biomarkers
Award | October 09, 2023
Finalist list of the European Lifestars Awards – Celebrating Life Science eXecutives & their partners!
Award | March 28, 2023
We won the Medical Diagnostic trophy at the 2nd edition of the “Healthtech awards” organised by France Biotech!
Scientific Publications
Annals of General Psychiatry | February 24, 2025
RNA editing‑based biomarker blood test
Andrea Miranda‑Mendizabal, Diana Vetter, Juan Zambrano, Jeff Zarp, Victor Chavarría, Anna Giménez‑Palomo, Meritxell Gonzalez‑Campos, Marc Valenti, Lara Walczer Baldinazzo, Sara Siddi, Maurizio Ferrari, Dinah Weissmann, Chantal Henry, Josep Maria Haro, Lars Vedel Kessing and Eduard Vieta
International Journal of Molecular Sciences | December 03, 2024
RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders
Francisco J. Checa-Robles, Nicolas Salvetat, Christopher Cayzac, Mary Menhem, Mathieu Favier, Diana Vetter, Ilhème Ouna, João V. Nani, Mirian A. F. Hayashi, Elisa Brietzke, Dinah Weissmann
Journal of Affective Disorder | April 22, 2024
AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort
Nicolas Salvetat, Francisco Jesus Checa-Robles, Aurélie Delacrétaz, Christopher Cayzac, Benjamin Dubuc, Diana Vetter, Jacques Dainat, Jean-Philippe Lang, Franziska Gamma, Dinah Weissmann
Psychiatry Research | September 10, 2023
Euthymic and depressed bipolar patients are characterized by different RNA editing patterns in blood
Mirian A.F. Hayashi, Nicolas Salvetat, Christopher Cayzac, Francisco Jesus Checa-Robles, Benjamin Dubuc, Sandie Mereuze, João V. Nani, Franck Molina, Elisa Brietzke, Dinah Weissmann
Translational Psychiatry | July 06, 2022
A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers
Nicolas Salvetat, Francisco Jesus Checa-Robles, Vipul Patel, Christopher Cayzac, Benjamin Dubuc, Fabrice Chimienti, Jean-Daniel Abraham, Pierrick Dupré, Diana Vetter, Sandie Méreuze, Jean-Philippe Lang, David J. Kupfer, Philippe Courtet, Dinah Weissmann
Translational Psychiatry | March 05, 2021
Phosphodiesterase 8A to discriminate in blood samples depressed patients and suicide attempters from healthy controls based on A-to-I RNA editing modifications
Nicolas Salvetat, Fabrice Chimienti, Christopher Cayzac, Benjamin Dubuc, Francisco Checa-Robles, Pierrick Dupre, Sandie Mereuze, Vipul Patel, Catherine Genty, Jean-Philippe Lang, Jean-François Pujol, Philippe Courtet & Dinah Weissmann
Journal of NeuroVirology | October 21, 2019
RNA editing blood biomarkers for predicting mood alterations in HCV patients
N. Salvetat, S. Van der Laan, B. Vire, F. Chimienti, S. Cleophax, J. P. Bronowicki, M. Doffoel, M. Bourlière, R. Schwan, J. P. Lang, J. F. Pujol, D. Weissmann
Translational Psychiatry | February 15, 2019
Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents
Fabrice Chimienti, Laurent Cavarec, Laurent Vincent, Nicolas Salvetat, Victoria Arango, Mark D. Underwood, J. John Mann, Jean-François Pujol, Dinah Weissmann
Drug Discovery Today | April 14, 2017
Emerging RNA editing biomarkers will foster drug development
S. Van der Laan, S. Salvetat, D. Weissmann, F. Molina
Translational Psychiatry | August 30, 2016
Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression
D Weissmann, S van der Laan, MD Underwood, N Salvetat, L Cavarec, L Vincent, F Molina, JJ Mann, V Arango and JF Pujol